Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Times Interest Earned (2023 - 2025)

Historic Times Interest Earned for Inhibrx Biosciences (INBX) over the last 3 years, with Q3 2025 value amounting to -$10.63.

  • Inhibrx Biosciences' Times Interest Earned changed N/A to -$10.63 in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.09, marking a year-over-year decrease of 36.79%. This contributed to the annual value of -$24.57 for FY2024, which is 25683.07% down from last year.
  • Per Inhibrx Biosciences' latest filing, its Times Interest Earned stood at -$10.63 for Q3 2025.
  • Over the past 5 years, Inhibrx Biosciences' Times Interest Earned peaked at -$5.23 during Q2 2023, and registered a low of -$30.01 during Q2 2024.
  • Over the past 3 years, Inhibrx Biosciences' median Times Interest Earned value was -$9.85 (recorded in 2024), while the average stood at -$12.0.
  • In the last 5 years, Inhibrx Biosciences' Times Interest Earned tumbled by 47391.39% in 2024 and then surged by 7094.62% in 2025.
  • Inhibrx Biosciences' Times Interest Earned (Quarter) stood at -$10.74 in 2023, then tumbled by 179.53% to -$30.01 in 2024, then surged by 64.58% to -$10.63 in 2025.
  • Its Times Interest Earned was -$10.63 in Q3 2025, compared to -$8.72 in Q2 2025 and -$15.95 in Q1 2025.